MedTrace Logo

Sleep Apnea in Head and Neck Cancer Patients at the University of Colorado

NCT04922112 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-08-02

No results posted yet for this study

Summary

Obstructive sleep apnea (OSA) is increasingly recognized in patients with squamous cell carcinoma of the head and neck (SCCHN). The prevalence prior and after cancer therapy is not well understood. OSA is identified as a contributing factor for daytime somnolence and quality of life (QOL), yet treatment of OSA in the SCCHN population has not been studied. The investigators hope to identify the disease course of sleep apnea, risk factors for development, and impact on QOL with treatment of OSA in a population of patients with SCCHN.

Conditions

Interventions

DIAGNOSTIC_TEST

Obstructive sleep apnea testing

* Functional Outcomes of Sleep Questionnaire (FOSQ-10) * European Organization for Research and Treatment of Cancer Head and Neck Survey (EORTC HN 35) * Epworth Sleepiness Scale (ESS) * Adult Comorbidity Evaluation (ACE 27) * University of Washington Quality of Life Questionnaire (UW-QOL) * Chronic Pain Assessment Questionnaire

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-20
Primary Completion
2022-09-28
Completion
2022-09-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04922112 on ClinicalTrials.gov